多药共用与2型糖尿病共病抑郁患者抗抑郁药可接受性:英国初级保健队列研究
本研究基于英国初级保健数据库2000至2018年数据,纳入73 808例首次开始抗抑郁药治疗的抑郁与2型糖尿病共病患者,使用Cox回归分析同时处方药物数量与早期抗抑郁药停药的关联。结果显示,同时处方药物中位数为7种,32周内44.26%完全停药、11.75%换药;同时用药数量与完全停药呈负相关(HR 0.45,95%CI 0.37~0.55),与换药无关联。
要点
- 2型糖尿病共病抑郁患者开始抗抑郁药治疗时,同时处方药物中位数达7种。
- 32周内44.26%完全停用抗抑郁药,11.75%更换抗抑郁药。
- 同时用药数量越多,早期完全停药风险越低(HR 0.45,95%CI 0.37~0.55)。
核心结论
- 2型糖尿病共病抑郁成人中早期停用抗抑郁药常见,但同时处方药物较多者可能更坚持治疗。
- 同时用药数量与完全停药呈负相关,与换药无关联。
研究设计与样本
- 纳入73 808例首次开始抗抑郁药治疗的抑郁与2型糖尿病共病成人。
- 采用惩罚B样条Cox回归分析同时处方药物数量与结局的关联。
主要发现
- 同时处方药物中位数为7种。
- 32周内44.26%(n=32 665)完全停用抗抑郁药,11.75%(n=8 672)更换抗抑郁药。
- 同时用药中位数7种与早期完全停药减少65.06%相关(HR 0.45,95%CI 0.37~0.55)。
- 未发现同时用药数量与更换抗抑郁药之间的关联证据。
临床怎么用
- 对同时用药较少的2型糖尿病共病抑郁患者,可考虑加强抗抑郁药依从性支持。
- 同时用药较多者可能代表躯体或心理健康更差,需综合评估而非简单归因于多药共用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Polypharmacy may increase the risk of drug interactions, side effects, and poor adherence; however, the impact of polypharmacy on antidepressant acceptability in individuals with type 2 diabetes (T2DM) is unknown. AIM: To investigate the association between number of prescribed medications and early antidepressant discontinuation in adults with T2DM. DESIGN AND SETTING: Cohort study using UK primary care data from the Clinical Practice Research Datalink between 1 January 2000 and 31 December 2018. METHOD: Cox regression with penalised B-splines was used to describe the association between the number of concurrently prescribed medications at the time of starting antidepressant treatment and each of the outcomes. RESULTS: A total of 73 808 individuals with comorbid depression and T2DM starting antidepressant treatment for the first time were identified. A median of 7 concurrent medications were prescribed. Within 32 weeks, 44.26% (n = 32 665) of participants discontinued antidepressant treatment altogether, and 11.75% (n = 8672) of participants switched antidepressant agents. An inverse relationship between the number of concurrent medications and discontinuing antidepressant treatment altogether was found. The median of 7 concurrent medications was associated with a 65.06% decrease in early antidepressant discontinuation; hazard ratio 0.45, 95% confidence interval = 0.37 to 0.55. No evidence of an association between the number of concurrent medications and switching antidepressant agents was found. CONCLUSION: Early discontinuation of antidepressants is common in adults with T2DM; however, individuals with higher levels of concurrent polypharmacy may be more adherent to treatment. These are likely to represent individuals with worse physical or mental health. Individuals with lower levels of concurrent polypharmacy may benefit from adherence support.
引用
- Jeffery A, Bhanu C, Walters K, et al. Polypharmacy and antidepressant acceptability in comorbid depression and type 2 diabetes: a cohort study using UK primary care data. Br J Gen Pract. 2023. PMID: 37105749. doi:10.3399/BJGP.2022.0295
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。